Trafermin
Modify Date: 2024-01-26 13:05:53
Trafermin structure
|
Common Name | Trafermin | ||
|---|---|---|---|---|
| CAS Number | 131094-16-1 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C18H22O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of TraferminTrafermin is a recombinant human basic fibroblast growth factor (rhbFGF). Trafermin is a potent FGFR inhibitor. Trafermin improves degree of re-epithelialization. Trafermin can be used in research in skin healing[1]. |
| Name | Trafermin |
|---|
| Description | Trafermin is a recombinant human basic fibroblast growth factor (rhbFGF). Trafermin is a potent FGFR inhibitor. Trafermin improves degree of re-epithelialization. Trafermin can be used in research in skin healing[1]. |
|---|---|
| Related Catalog | |
| In Vivo | Trafermin (trafermin is applied by spray) promotes skin healing in with cutaneous ulcer model mice and wound healing rates are 47.40% at 7 days and 93.61% at 14 days. Trafermin increases the expression of TGF-β1 and α-SMA[1]. |
| Molecular Formula | C18H22O2 |
|---|